2008
EFFECTS OF TARANABANT, A NOVEL CANNABINOID 1 RECEPTOR (CB-1R) INVERSE AGONIST, ON WEIGHT REDUCTION IN OBESE PATIENTS OVER 12 WEEKS
Carr R, Erondu N, Gonzalez C, Gumbiner B, Musser B, Lu K, Capece R, Klein S, Ravussin E, Amatruda J, Heymsfield S. EFFECTS OF TARANABANT, A NOVEL CANNABINOID 1 RECEPTOR (CB-1R) INVERSE AGONIST, ON WEIGHT REDUCTION IN OBESE PATIENTS OVER 12 WEEKS. Atherosclerosis Plus 2008, 9: 209. DOI: 10.1016/s1567-5688(08)70835-3.Peer-Reviewed Original Research
1995
The effects of weight reduction to ideal body weight on body fat distribution
Hendler R, Welle S, Statt M, Barnard R, Amatruda J. The effects of weight reduction to ideal body weight on body fat distribution. Metabolism 1995, 44: 1413-1416. PMID: 7476327, DOI: 10.1016/0026-0495(95)90139-6.Peer-Reviewed Original ResearchConceptsIdeal body weightSubcutaneous fat areaBody mass indexFat areaObese womenFat distributionObese subjectsBody fatBody weightUpper body fat distributionIntraabdominal fat areaObese control subjectsBody fat distributionPercent body fatHealth risk factorsWeight reductionObese groupMass indexHip ratioControl subjectsRisk factorsMetabolic disordersControl groupWeight lossObese
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply